David Siwicki
Impact in
- Psychiatry and Mental health top 10%
- Attention Deficit Hyperactivity Disorder
-
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 12
-
- Attention Deficit Hyperactivity Disorder 10
- Co-authors
- Kenneth Blum (21 shared papers)Rajendra D. Badgaiyan (18 shared papers)Edward J. Modestino (14 shared papers)Mary Hauser (11 shared papers)Bruce Steinberg (9 shared papers)Lisa Lott (8 shared papers)David Baron (9 shared papers)Brent Boyett (8 shared papers)
- Journals
- Current Pharmaceutical Biotechnology (1 paper)Journal of Behavioral Addictions (1 paper)Molecular Neurobiology (1 paper)PubMed (17 papers)
- Partner nations
- United StatesHungaryIndia
In The Last Decade
David Siwicki
21 papers receiving 308 citations
Peers
Comparison fields: 5 of 49
- Psychiatry and Mental health 141
- Cellular and Molecular Neuroscience 154
- Pharmacology 119
- Biological Psychiatry 16
- Behavioral Neuroscience 15
Countries citing papers authored by David Siwicki
This map shows the geographic impact of David Siwicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Siwicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Siwicki more than expected).
Fields of papers citing papers by David Siwicki
This network shows the impact of papers produced by David Siwicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Siwicki. The network helps show where David Siwicki may publish in the future.
Co-authors
The 25 scholars most cited alongside David Siwicki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 40 | |
| 2 | 2019 | 25 | |
| 3 | 2020 | 25 | |
| 4 | 2018 | 23 | |
| 5 | 2019 | 20 | |
| 6 | Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse. | 2018 | 17 |
| 7 | 2018 | 16 | |
| 8 | 2019 | 16 | |
| 9 | 2017 | 15 | |
| 10 | GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM™): LESSONS LEARNED FROM AMERICA. | 2017 | 14 |
| 11 | 2018 | 12 | |
| 12 | 2018 | 12 | |
| 13 | Insurance Companies Fighting the Peer Review Empire without any Validity: the Case for Addiction and Pain Modalities in the face of an American Drug Epidemic. | 2018 | 12 |
| 14 | 2019 | 10 | |
| 15 | 2018 | 9 | |
| 16 | 2020 | 9 | |
| 17 | 2017 | 9 | |
| 18 | Introducing "Precision Addiction Management (PAM®)" as an Adjunctive Genetic Guided Therapy for Abusable Drugs in America. | 2018 | 9 |
| 19 | 2018 | 8 | |
| 20 | 2020 | 7 |
About David Siwicki
David Siwicki is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health, Pharmacology, Clinical Psychology and Epidemiology, having authored 21 papers that have together received 311 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (12 papers), Attention Deficit Hyperactivity Disorder (10 papers), Substance Abuse Treatment and Outcomes (4 papers), Treatment of Major Depression (4 papers), Opioid Use Disorder Treatment (3 papers), Pharmacology and Obesity Treatment (2 papers), Trypanosoma species research and implications (1 paper) and Neurology and Historical Studies (1 paper). The work is most often cited by research in Psychiatry and Mental health (141 citations), Cellular and Molecular Neuroscience (154 citations), Pharmacology (119 citations), Biological Psychiatry (16 citations) and Behavioral Neuroscience (15 citations). David Siwicki has collaborated with scholars based in United States, Hungary and India. Frequent co-authors include Kenneth Blum, Rajendra D. Badgaiyan, Edward J. Modestino, Mary Hauser, Bruce Steinberg, Lisa Lott, David Baron, Brent Boyett, Thomas McLaughlin and Marjorie C. Gondré‐Lewis. Their work appears in journals such as Current Pharmaceutical Biotechnology, Journal of Behavioral Addictions, Molecular Neurobiology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.